题名 | Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial |
链接 | https://pubmed.ncbi.nlm.nih.gov/32333875/ |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |